Author
Listed:
- Yalda Afshar
(University of California, Los Angeles)
- Jiantong Dong
(University of California, Los Angeles
Peking University)
- Pan Zhao
(The First Affiliated Hospital of Southern University of Science and Technology, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital)
- Lei Li
(University of California, Los Angeles
Shandong Provincial Hospital Affiliated to Shandong University)
- Shan Wang
(University of California, Los Angeles
Shandong Provincial Hospital Affiliated to Shandong University)
- Ryan Y. Zhang
(University of California, Los Angeles)
- Ceng Zhang
(University of California, Los Angeles)
- Ophelia Yin
(University of California, Los Angeles)
- Christina S. Han
(University of California, Los Angeles
Center for Fetal Medicine and Women’s Ultrasound)
- Brett D. Einerson
(University of Utah Health)
- Tania L. Gonzalez
(Cedars-Sinai Medical Center)
- Huirong Zhang
(The First Affiliated Hospital of Southern University of Science and Technology, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital)
- Anqi Zhou
(University of California, Los Angeles)
- Zhuo Yang
(University of California, Los Angeles)
- Shih-Jie Chou
(University of California, Los Angeles)
- Na Sun
(University of California, Los Angeles)
- Ju Cheng
(University of California, Los Angeles)
- Henan Zhu
(University of California, Los Angeles)
- Jing Wang
(University of California, Los Angeles)
- Tiffany X. Zhang
(University of California, Los Angeles)
- Yi-Te Lee
(University of California, Los Angeles)
- Jasmine J. Wang
(Cedars-Sinai Medical Center)
- Pai-Chi Teng
(Cedars-Sinai Medical Center)
- Peng Yang
(University of California, Los Angeles)
- Dongping Qi
(University of California, Los Angeles)
- Meiping Zhao
(Peking University)
- Myung-Shin Sim
(University of California, Los Angeles)
- Ruilian Zhe
(The First Affiliated Hospital of Southern University of Science and Technology, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital)
- Jeffrey D. Goldstein
(University of California, Los Angeles)
- John Williams
(Cedars-Sinai Medical Center)
- Xietong Wang
(Shandong Provincial Hospital Affiliated to Shandong University)
- Qingying Zhang
(University of California, Los Angeles
Fudan University)
- Lawrence D. Platt
(University of California, Los Angeles
Center for Fetal Medicine and Women’s Ultrasound)
- Chang Zou
(The First Affiliated Hospital of Southern University of Science and Technology, The Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital)
- Margareta D. Pisarska
(Cedars-Sinai Medical Center)
- Hsian-Rong Tseng
(University of California, Los Angeles)
- Yazhen Zhu
(University of California, Los Angeles)
Abstract
Placenta accreta spectrum (PAS) is a high-risk obstetrical condition associated with significant morbidity and mortality. Current clinical screening modalities for PAS are not always conclusive. Here, we report a nanostructure-embedded microchip that efficiently enriches both single and clustered circulating trophoblasts (cTBs) from maternal blood for detecting PAS. We discover a uniquely high prevalence of cTB-clusters in PAS and subsequently optimize the device to preserve the intactness of these clusters. Our feasibility study on the enumeration of cTBs and cTB-clusters from 168 pregnant women demonstrates excellent diagnostic performance for distinguishing PAS from non-PAS. A logistic regression model is constructed using a training cohort and then cross-validated and tested using an independent cohort. The combined cTB assay achieves an Area Under ROC Curve of 0.942 (throughout gestation) and 0.924 (early gestation) for distinguishing PAS from non-PAS. Our assay holds the potential to improve current diagnostic modalities for the early detection of PAS.
Suggested Citation
Yalda Afshar & Jiantong Dong & Pan Zhao & Lei Li & Shan Wang & Ryan Y. Zhang & Ceng Zhang & Ophelia Yin & Christina S. Han & Brett D. Einerson & Tania L. Gonzalez & Huirong Zhang & Anqi Zhou & Zhuo Ya, 2021.
"Circulating trophoblast cell clusters for early detection of placenta accreta spectrum disorders,"
Nature Communications, Nature, vol. 12(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24627-2
DOI: 10.1038/s41467-021-24627-2
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24627-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.